U.S. Representative Elissa Slotkin (D-MI) issued a press release Aug. 8 highlighting her introduction of the American Made Pharmaceuticals Acts that included a quote of support from MHA CEO Brian Peters. The bipartisan bill, introduced with U.S. Rep. Don Bacon (R-NE), would incentivize domestic production of critical medicines and help prevent drug shortages by securing the pharmaceutical supply chain. Its Senate companion is led by Sens. Tina Smith (D-MN) and Tom Cotton (R-AR).
“Drug shortages severely hamper a hospital’s ability to provide every patient with the best treatment,” said Peters. “We applaud Rep. Slotkin for leading on this important issue and introducing legislation that should increase domestic pharmaceutical manufacturing, strengthen our pharmaceutical supply chain and prevent future drug shortages.”
Members with any questions regarding media requests should contact John Karasinski at the MHA.